🧠 Neuralink Implants Brain Chip

Plus: Diversity in AI isn’t opinion, it’s math

Author

Kaushee Ganeshan
January 30, 2024

Logo

Together with

Welcome to your briefing:

  • AI ROUNDUP: DOJ’s healthcare probes of AI tools rooted in Purdue Pharma case

  • INDUSTRY ROUNDUP: Mental health and addiction care falls short because it's not profitable

  • INTERESTING READS: 1 simple habit boosts brain connectivity, learning, and memory

  • INSIGHTS CORNER: Key barriers to AI in drug discovery in developed countries

  • TRIVIA: What did a neural network looking for skin cancer in biopsy images incorrectly base its diagnosis on?

AI ROUNDUP

  • Elon Musk's Neuralink implants brain chip in first human (Read More)

  • A first in London: Total knee replacement assisted by Augmented Reality (Read More)

  • NHS data sale can fuel tech boom (Read More)

  • DOJ’s healthcare probes of AI tools rooted in Purdue pharma case (Read More)

  • How Dubai is using AI to detect health risks and cut treatment costs (Read More)

  • The importance of diversity in AI isn’t opinion, it’s math (Read More)

  • How could AI help pregnant women In Zambia? (Read More)

  • Boston Children’s Researchers deploy AI across their hip clinics (Read More)

  • Gene therapy shows promise for an inherited form of deafness (Read More)

INDUSTRY ROUNDUP

  • This is the greatest risk factor of death in people with obesity (Read More)

  • Mental health and addiction care falls short because it's not profitable (Read More)

  • Ouch. That free annual checkup might cost you. Here’s why (Read More)

  • Big pharma approaches patent cliff (Read More)

  • Biden administration to launch Instacart partnership as part of Food is Medicine summit (Read More)

INTERESTING READS

  • 1 simple habit boosts brain connectivity, learning, and memory (Read More)

  • Three days that changed the thinking about black women’s health (Read More)

  • Resolve to get healthier, lose weight? Setting BMI goal might not be best way (Read More)

Transform your approach to weight loss with the prescribed medication Semaglutide, from Weightcare

Accessible telemedicine, and affordable monthly subscriptions,it’s never been easier to use  Semaglutide, to reach your health goals. 

What’s Included?

✓ Initial Telehealth Visit

✓ Prescription + Medication

✓ Unlimited Physician Support

✓ Monthly Check-ins

✓ Delivered to your Door

INSIGHTS CORNER

#1 - Key Barriers To Adopting AI For Drug Discovery In Developed Countries

A 2023 survey reveals that the main obstacle to integrating AI in drug discovery in high-income countries is the availability of high-quality data. Additional challenges include finding qualified staff and a general lack of AI understanding.

#2 - Measuring ROI In Generative AI

Businesses aiming to leverage GenAI should strategically balance immediate gains with long-term transformative goals. Quick wins, such as productivity enhancements from tools like Microsoft 365 Copilot, are beneficial; however, the true competitive edge lies in integrating GenAI into unique, industry-specific use cases. Moreover, comprehensive transformative initiatives that leverage GenAI could redefine business models.

However, as Gartner suggests, a prudent approach is key due to the anticipated downturn in 90% of GenAI projects by 2025, primarily due to rising costs and complexities.

Timeline for Value:

  • Quick wins in less than a year

  • Differentiating initiatives in 1-2 years.

  • Transformational impacts in over two years.

Actionable Steps:

  • Implement quick-win GenAI tools for immediate productivity.

  • Pursue unique GenAI applications for competitive differentiation.

  • Plan for transformative GenAI initiatives, balancing risk and potential leadership gains.

#3- Trend: Post-Holiday Drop in COVID and RSV, Yet Respiratory Illnesses Remain Elevated

As of January 13, 2024, CDC data shows a post-holiday decline in COVID-19 and RSV cases, but respiratory illnesses remain high in the U.S. with 22 jurisdictions reporting "high" or "very high" activity, down from 37. Flu remains a concern with a 14% positivity rate. The most viral activity was detected in the South, particularly in Tennessee, Louisiana, South Carolina, New Mexico, and New York City.

AI TRIVIA

HEALTHCARE CONFERENCES

MARCH 

That’s all for today, follow me on Linkedin. Support us by sharing our newsletter with your colleagues.

Until next time,

Kaushee